CYPHERPUNK TECHNOLOGIES INC.
CYPH · Pharmaceutical Preparations
Latest available SEC filing: 4 ·
Latest disclosures
-
Winklevoss Capital Fund, LLC: Form 4
Insider disclosure · Filed · Report period 12 Oct 2026
-
Form 4
SEC filing · Filed
-
Form 4
SEC filing · Filed
-
Form 4
SEC filing · Filed
-
Form 4
SEC filing · Filed
-
Form 3
SEC filing · Filed
-
Form 4
SEC filing · Filed
-
Latest financial period: Q2 2026
Financial facts · Filed
Institutional holders by security
Choose a share class to see reported 13F positions and quarterly changes. Different securities have separate holder histories.
Company details and SEC sources
CIK 0001509745 · SEC filing index. Filing dates describe disclosures, not live market data.
- Listed symbols
- CYPH on Nasdaq
- SEC industry group
- Pharmaceutical Preparations (Office of Life Sciences)
- Business address
- 47 Thorndike Street, Suite B1 1, Cambridge, MA, 02142
- Incorporated in
- DE
- Fiscal year end
- 31 December
- Former names on EDGAR
- LEAP THERAPEUTICS, INC. (to 12 Nov 2025), Dekkun Corp (to 07 Jan 2011)
At a glance
Names, identifiers, and filing context for this profile.
2 identity fields